Endourologic Treatment of the Upper Urinary Tract Obstruction in the Advanced Cancer Patients.
- Author:
Jae Cheon AHN
1
;
Seong CHOI
;
Hyun Yul RHEW
Author Information
1. Department of Urology, Kosin University, College of Medicine, Pusan, Korea.
- Publication Type:Original Article
- Keywords:
cancer;
ureter obstruction;
endourology
- MeSH:
Hematuria;
Humans;
Neoplasm Metastasis;
Pregnenolone Carbonitrile;
Quality of Life;
Stents;
Ureteral Obstruction;
Urinary Tract*
- From:Korean Journal of Urology
1996;37(3):301-307
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Palliative endourologic treatment was done in 94 cases for ureteral obstruction secondary to advanced malignancy The average survival was 4.2 months. The obstruction were caused by metastases or invasion of cancer in all patients. First we tried to insert a double J stent(STENT), when it failed percutaneous nephrostomy(PCN) was performed. Initially 16 patients were treated by STENT and 8 patients by PCN. The SIENT was changed 2.2 times on the average in all patients. 75% of the patients who had been treated by STENT experienced only one or two times of STENT changes before dying. Patency period of the STENT was 57.6 days on the average. The patency period was shorter in the patients who showed gross hematuria at the time of STENT insertion. Although survival was not so long, 60.6% patients were able to return to their homes. The endourologic management of the upper urinary tract obstruction will play a more important role and offer a better quality of life for end stage cancer patients.
